Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
The Gates Foundation Is Funding A Startup’s Plan To Fight Malnutrition With Bacteria
The Bill & Melinda Gates Foundation has pledged new funding to Kanvas Biosciences to develop a synthetic microbiome pill aimed at treating environmental enteric dysfunction (EED), a gut‑inflammation disease that threatens roughly 150 million children worldwide. Kanvas uses machine‑learning‑driven microbiome mapping to combine up to 145 bacterial strains into a single oral capsule, far exceeding the strain count of existing microbiome therapies. The program targets pregnant women, hoping to improve maternal health and seed a healthier gut flora in newborns. The effort faces formulation, stability and adherence hurdles before clinical rollout.
Makary’s Grip Slips at FDA, Triggering Speculation on Successor
White House leaks indicate President Donald Trump is increasingly dissatisfied with FDA Commissioner Marty Makary, shifting speculation from if to when he might be removed. The immediate catalyst appears to be Makary’s slow approval of flavored vaping products, a decision...
Will Insurance Cover Neck Surgery Implants? Spine Societies Speak Out
A growing number of insurers are refusing to reimburse interbody spacers used in anterior cervical discectomy and fusion (ACDF), labeling them experimental despite a quarter‑century of clinical use. Major spine societies—including AANS, CNS, NASS and SRS—have issued a unified statement...
Trump Reportedly Plans to Fire FDA Commissioner Marty Makary
President Donald Trump has signaled a plan to dismiss FDA Commissioner Marty Makary, according to multiple reports from the Wall Street Journal, Bloomberg, Washington Post, and Politico. The move follows intense pressure from the White House over Makary’s hesitation to...
Bridging Gaps in Rural Healthcare: How AI and Collaboration Drive Efficiency
Pivot Point Consulting has teamed with Microsoft to deliver the AI‑powered Dragon Copilot to rural hospitals at a 60% discount off MSRP. The solution adds ambient clinical listening, automated documentation and real‑time visit summarization, aiming to cut clinician workload and...
Tr1X: Inducing Long-Term Immune Tolerance with Allogeneic Tr1 Cells
BioCentury has updated its website privacy framework, detailing the use of strict, functional, marketing, advertising, and analytics cookies. The policy explains that essential cookies enable authentication, registration, and navigation, while functional cookies enhance personalization. Marketing and advertising cookies are used...
New Brain Scan Index Detects Hidden Alzheimer’s Patterns Before Memory Loss Begins
Researchers at the University of Texas Health Science Center have introduced the Regional Vulnerability Index, a mathematical tool that evaluates standard MRI scans for Alzheimer’s‑like structural patterns. The index quantifies how closely an individual’s brain matches a disease blueprint, revealing...
:max_bytes(150000):strip_icc():format(jpeg)/elder-FreshSplash-869fb2e6e548431bb1760905c2d64bb5.png)
Paying for Elder Care in 2026: How Home Caregiver Costs Vary by State
In 2026 the median hourly cost for a home caregiver rose to $34, a 3% increase from the prior year. Prices vary dramatically by state, from $25 per hour in Mississippi to $44 in South Dakota, driven primarily by geography...
American Healthcare REIT: Trilogy’s MA Strategy, Integrated Nursing Home-AL Campuses Drive Margins
American Healthcare REIT (AHR) highlighted Trilogy Health Services' integrated skilled‑nursing and assisted‑living model, which delivered 14.5% same‑store NOI growth and 91.2% occupancy in Q1. The fee‑free CCRC‑style campuses attracted higher Medicare Advantage rates and strong private‑pay mix, pushing same‑store NOI...
Nonprofit Hospital Tax Break Costs $300B in Ten Years
Worth noting: Based on CRFB's "2024 estimates, the tax exemption for nonprofit hospitals will cost the federal government nearly $300 billion in lost revenue over the next decade."
Mikey Adams Talks Radio, MaineCare Fraud and the Fight for Common Sense - MWTV
In this episode of MainWire TV, host Tom Shattuck chats with Boston‑Connecticut radio veteran Mikey Adams and MainWire editor Steve Robinson about the decline of free‑wheeling radio, past scandals like Adams’s 1994 cannabis bust, and the current wave of fraud...
FDA Under Gottlieb Proposed Menthol and Flavored E‑cigarette Ban
In Trump's first term, the FDA under @ScottGottliebMD proposed a ban on menthol cigarettes and most flavored electronic cigarettes
FDA Approves Ocrevus for Relapsing-Remitting MS in Children Aged 10 Years and Up
The U.S. Food and Drug Administration has approved Genentech's ocrelizumab (Ocrevus) for children aged 10 and older who weigh at least 55 lb, expanding its use beyond adult multiple sclerosis (MS) populations. The decision follows the OPERETTA II trial, which demonstrated superior...
Banning SSRIs Is Unreasonable for Mental Health Care
Absolutely batshit. Can we do better on mental health. Of course. Is banning SSRI even remotely a good idea - not unless you are an utter doctrinaire moron.
Development and Validation of a Multimodal Interpretable Machine Learning Model with SHAP for Malignancy Risk Prediction in Bethesda III Thyroid...
Researchers created a multimodal, interpretable machine‑learning model that combines clinical data, ultrasound features, and BRAF V600E mutation status to predict malignancy in Bethesda III thyroid nodules. In a dual‑center study of 490 patients, the fusion model achieved an AUC of 0.959 in...
Resource Allocation Challenges in Critical Care Nursing: A Cross-Sectional Study of Public Hospitals
A cross‑sectional survey of 200 critical‑care nurses in two Ahmedabad public hospitals identified resource shortages as the dominant operational challenge. Deficiencies in human and material resources represented roughly 27% of the overall challenge burden, while ICU‑related stressors accounted for about...
‘Demographics Are Destiny’ in Palliative Care
The aging U.S. population is driving a shift toward home‑based palliative care. VITAS Healthcare vice president Jennifer O’Neill warned that workforce growth is lagging behind patient demand and highlighted the need for staff and family education. Industry leaders such as...
Addressing Manufacturing and Access Barriers in Advanced Therapeutics
Advanced cell and gene therapies are moving from research to commercial markets, but their complex manufacturing creates variability that delays patient access. Industry leaders are deploying process analytical technologies (PAT) and artificial intelligence (AI) to gain real‑time insight and predictive...
HIV Advocates Ask Regulators In Multiple States To Probe Highmark’s ‘Copay Armor’ Policy
The HIV+HEP Policy Institute has asked insurance regulators in Delaware, Pennsylvania and West Virginia to investigate Highmark Blue Cross Blue Shield’s 2026 exchange plans. The group alleges the plans use a “Copay Armor” or copay‑maximizer program that raises out‑of‑pocket costs...
Cigna Getting Out of Individual ACA Market
Cigna announced it will wind down its individual ACA exchange business by the end of 2026, citing a shrinking customer base and a need to concentrate on core growth platforms. The insurer’s enrollment fell to 355,000 this quarter, down from...
INBX to Release INBRX‑106 Phase 2 Data Monday
$INBX reporting INBRX-106 ph2 data on Monday. This is the ox40 cancer drug that reportedly drew interest from Merck and others?
Mixed-Methods Evaluation of a Multi-Level, Multi-Component Implementation Theory: Results From Scaling Up Obstetric Triage in Six Referral Hospitals in Ghana
A midwife‑led obstetric triage system (OTIP) was scaled across six Ghanaian referral hospitals. Within 12 months, women assessed within 10 minutes rose from 5% to 85%, with 96% adoption of color‑coded wristbands and 83% accurate risk classification. Implementation outcomes showed...
Nobel Prize-Winning Economist Alvin Roth on Organ Markets
Nobel laureate Alvin Roth argues in a Washington Post op‑ed that the United States should legalize payments for kidney donors. He cites roughly 130,000 new kidney‑failure cases each year, a $55 billion Medicare burden, and a waiting list of 90,000 patients...
VA Whole Health Model Boosts Function for Veterans with Chronic Pain
A VA‑wide trial across six health systems found that veterans receiving Whole Health, a whole‑person approach that integrates sleep, movement, stress and personal goals, showed modest but measurable gains in daily function after a year, outperforming standard care and group...
Economic Assistance and Incentives for Drug Development
The FDA and other federal agencies offer a suite of pre‑approval assistance and post‑approval incentives to lower the financial risk of drug development. Programs such as the Orphan Products Grant, SBIR/STTR funding, and PDUFA fee waivers help sponsors fund clinical...
TikTok-Driven Supplement Sales Face Safety Scrutiny After Recall and Illness Reports
A wave of adverse health events tied to supplements popularized on TikTok has triggered product recalls and heightened FDA warnings. The incidents, ranging from salmonella outbreaks to liver damage, underscore growing concerns over the safety and labeling of influencer‑driven nutraceuticals.
MRNA Nanoparticles Reprogram T Cells In Vivo, Show Promise
Impressive. In vivo reprogramming of killer T cells with mRNA-nanoparticle packaging in non-human primates. Multiple use cases in the clinic vs pathogens and cancer, no less an alternative version vs autoimmune diseases https://t.co/ddhebnxvkE @SciImmunology
AstraZeneca and Daiichi Sankyo Secure Earlier‑Line Enhertu Approvals in South Korea
AstraZeneca and Daiichi Sankyo announced that South Korea’s Ministry of Food and Drug Safety approved Enhertu for first‑line metastatic HER2‑positive breast cancer and second‑line HER2‑positive gastric cancer. The decisions, based on DESTINY‑Breast09 and DESTINY‑Gastric04 trials, could broaden the drug’s Asian...
:max_bytes(150000):strip_icc():format(jpeg)/VWM-GettyImages-1476743519-09d99796c8494685a23f87a861445ac1.jpg)
6 Signs It's Time to Talk to a Mental Health Professional
Living with diabetes can trigger emotional strain that goes beyond blood‑sugar control, manifesting as diabetes distress, burnout, or depression. The CDC reports that 24% of adults with diabetes experience moderate distress and 7% severe, which correlates with poorer self‑management and...
Menu-Order AI Deploys GLP‑1‑Driven Nutrition Guidance to 100,000 Users
Menu-Order AI, founded by Melissa Butler, has rolled out an AI‑driven ordering platform that offers real‑time, GLP‑1‑aligned menu recommendations. The app has logged more than 100,000 global downloads, positioning it at the intersection of preventive health and the restaurant sector.
Google Health App Launches in India with AI Coach and Rs. 99 Premium Plan
Google announced the public rollout of its rebranded Google Health app and AI‑powered Health Coach in India, beginning May 19 and expanding to all eligible users by May 26. The service includes a premium subscription priced at Rs. 99 per month (about $1.20),...
Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
Odyssey Therapeutics priced 15.5 million shares at $18, raising $304 million including a $25.2 million private placement. The funds will finance Phase 2a/2b trials of OD‑001, an oral RIPK2 inhibitor for ulcerative colitis, and advance OD‑002, a SLC15A4 inhibitor, toward Phase 1/2a. Odyssey’s platform targets...
How to Manage a Virtualization Migration in Healthcare
Healthcare providers are accelerating migrations to new virtualization platforms as rising license fees and bundled pricing strain budgets. Executives like Nutanix’s Scott Ragsdale warn that a migration touches a decade of operational procedures, technical debt, and clinical workloads. Successful moves...
Former Cadillac CMO Melissa Grady Dias Becomes CEO of Measured Wellness
Melissa Grady Dias, who spent seven years as global CMO of Cadillac, has been appointed CEO of California‑based Measured Wellness. The health‑tech firm will tap her branding and digital expertise to accelerate a national rollout of its wearable‑data platform as...
Precision Neuroscience CEO on Medtronic Partnership, What's Next
Precision Neuroscience CEO Michael Mager announced a partnership with Medtronic to commercialize a reversible brain‑computer interface (BCI) that lets paralyzed users control digital devices with thought. The company has temporarily implanted 83 devices in volunteers under FDA clearance and is...
Where Addus, BrightSpring, Pennant See Upside In Fraud Crackdowns, Opportunity In M&A
Q1 2026 earnings reveal that home‑based care leaders are navigating two converging forces: a federal crackdown on fraud, waste and abuse, and a surge in M&A activity. BrightSpring and Pennant are still digesting their 2025 Amedisys acquisitions while scouting disciplined...
DOJ Accuses UCLA Medical School of Racial Preference for Black and Hispanic Applicants
The U.S. Justice Department says UCLA’s David Geffen School of Medicine intentionally discriminated in favor of Black and Hispanic candidates for the 2023‑2025 classes, violating Title VI after the Supreme Court’s 2023 ruling. The department seeks a voluntary settlement, while the...
Three in 10 AVRs in Adults Younger Than 65 Are Transcatheter
A registry analysis of 34,504 U.S. patients under 65 undergoing aortic valve replacement shows 28.5% received TAVI, up from 15.7% in 2016 and plateauing around 29% by 2024, while isolated SAVR fell from 43.8% to 27.0%. Growth in TAVI accelerated...
Exclusive-Kennedy's Health Officials Explored US Ban of some Widely Used Antidepressants, Sources Say
U.S. Health and Human Services officials recently examined whether to restrict certain selective serotonin reuptake inhibitors (SSRIs) such as Zoloft, Prozac and Lexapro, amid Health Secretary Robert F. Kennedy Jr.'s push to curb their use. Kennedy announced reimbursement guidelines for...
HIMSSCast: ‘Implement an AI Solution in Digestible Chunks’
Northwell Health Labs has integrated artificial intelligence into its revenue cycle management, achieving a 40% reduction in error rates. The AI was deployed in small, digestible chunks, allowing the system to generate quick wins and avoid the pitfalls of a...
Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs
Entera Bio reported Q1 2026 results, highlighting a streamlined Phase 3 protocol for its lead osteoporosis candidate EB613 and a completed Phase 1 bridging study that positions a single‑tablet formulation for the upcoming trial. The company also advanced its partnership with OPKO, securing...
Family Offices Surge in April, Allocating One‑Third of Deals to Health‑Tech
Family offices stepped up deal‑making in April, completing 55 direct investments—up from 39 in March—and earmarked almost a third of those for healthcare and life‑science firms. The rebound follows a slowdown triggered by the Iran conflict and reflects a growing...
Glaucoma, Hypertension May Be Linked to Dementia Risk
Researchers presented data linking glaucoma and hypertension to poorer cognitive performance, as measured by the Montreal Cognitive Assessment. The analysis used an AI‑ready electronic health record dataset to compare patients with and without glaucoma. Both conditions were more prevalent among...
COVID Response Coordinator Shares Why the Hantavirus Won’t Turn Into Another Pandemic
Former White House COVID‑19 response coordinator Dr. Ashish Jha told Good Morning America that the recent hantavirus outbreak on the Dutch cruise ship MV Hondius is unlikely to become a pandemic. He explained that hantavirus, especially the rare Andes strain,...
The $1 Trillion Cardiovascular Reset
The blog highlights Eli Lilly's $1.3 billion acquisition of Verve Therapeutics, targeting a one‑shot PCSK9 gene‑editing therapy that could replace daily statins. It underscores the massive adherence problem—up to 75% of statin users stop within two years—and the untapped 1.4 billion‑person market for...
Bristol Myers Squibb Accused of Buying Off Competitors to Delay Development of Generic Cancer Drugs
Centene Corp. filed a federal antitrust lawsuit accusing Bristol Myers Squibb (BMS) of conspiring with generic manufacturers to delay competition for lenalidomide and its brand version Revlimid. The complaint says BMS earned $5.2 billion in Revlimid sales in 2023 and raised...
Google Unveils Screenless Fitbit Air, New Google Health App
Google introduced the screenless Fitbit Air, a $99.99 wearable that tracks heart rate, sleep, oxygen, temperature and activity without a display. The device pairs with the rebranded Google Health app—formerly the Fitbit app—offering a unified dashboard that aggregates data from...
Proportion of Women Undergoing TAVI for Aortic Stenosis Declining in US
A decade‑long Medicare analysis shows the share of women undergoing transcatheter aortic valve implantation (TAVI) fell from 47.6% in 2013 to 43.6% in 2022, even as total procedure volumes surged. Women experienced higher periprocedural mortality (2.5% vs 2.2%), more vascular...
![[World Report] “We Don’t Want It to Happen to Others”: Suicide in Young Māori](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/84dff2305f673f64d60610ed84154a72.webp)
[World Report] “We Don’t Want It to Happen to Others”: Suicide in Young Māori
Suicide remains the leading cause of death for New Zealanders aged 15‑19, with Māori youth disproportionately affected. Recent research highlights a stark gap between Māori and non‑Māori suicide rates, underscoring systemic inequities. Advocates and community leaders are urging a shift toward...
![[Comment] Could Enpatoran Add to Our Therapeutic Toolbox in SLE?](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/34fb3ece9b6e61491e68aaab9182a7fc.webp)
[Comment] Could Enpatoran Add to Our Therapeutic Toolbox in SLE?
Systemic lupus erythematosus (SLE) remains a heterogeneous disease with only two novel agents—BAFF and type‑1 interferon receptor inhibitors—approved since the 1950s. These drugs often fall short as stand‑alone treatments, are expensive, and are not uniformly accessible worldwide. Clinicians continue to...